Back to Search
Start Over
Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
- Source :
-
Brain research [Brain Res] 2010 Feb 26; Vol. 1316, pp. 27-34. Date of Electronic Publication: 2009 Dec 22. - Publication Year :
- 2010
-
Abstract
- Astrocytes are responsible for the majority of the clearance of extracellular glutamate released during neuronal activity. dl-threo-beta-benzyloxyaspartate (TBOA) is extensively used as inhibitor of glutamate transport activity, but suffers from relatively low affinity for the transporter. Here, we characterized the effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), a recently developed inhibitor of the glutamate transporter on mouse cortical astrocytes in primary culture. The glial Na(+)-glutamate transport system is very efficient and its activation by glutamate causes rapid intracellular Na(+) concentration (Na(+)(i)) changes that enable real time monitoring of transporter activity. Na(+)(i) was monitored by fluorescence microscopy in single astrocytes using the fluorescent Na(+)-sensitive probe sodium-binding benzofuran isophtalate. When applied alone, TFB-TBOA, at a concentration of 1 microM, caused small alterations of Na(+)(i). TFB-TBOA inhibited the Na(+)(i) response evoked by 200 microM glutamate in a concentration-dependent manner with IC(50) value of 43+/-9 nM, as measured on the amplitude of the Na(+)(i) response. The maximum inhibition of glutamate-evoked Na(+)(i) increase by TFB-TBOA was >80%, but was only partly reversible. The residual response persisted in the presence of the AMPA/kainate receptor antagonist CNQX. TFB-TBOA also efficiently inhibited Na(+)(i) elevations caused by the application of d-aspartate, a transporter substrate that does not activate non-NMDA ionotropic receptors. TFB-TBOA was found not to influence the membrane properties of cultured cortical neurons recorded in whole-cell patch clamp. Thus, TFB-TBOA, with its high potency and its apparent lack of neuronal effects, appears to be one of the most useful pharmacological tools available so far for studying glial glutamate transporters.<br /> ((c) 2009 Elsevier B.V. All rights reserved.)
- Subjects :
- 6-Cyano-7-nitroquinoxaline-2,3-dione pharmacology
Animals
Aspartic Acid administration & dosage
Aspartic Acid pharmacology
Cells, Cultured
Central Nervous System Agents administration & dosage
Cerebral Cortex drug effects
Cerebral Cortex metabolism
D-Aspartic Acid metabolism
Excitatory Amino Acid Antagonists pharmacology
Glutamate Plasma Membrane Transport Proteins antagonists & inhibitors
Glutamate Plasma Membrane Transport Proteins metabolism
Intracellular Space drug effects
Intracellular Space metabolism
Membrane Potentials drug effects
Mice
Mice, Inbred C57BL
Neurons drug effects
Neurons physiology
Receptors, Kainic Acid antagonists & inhibitors
Receptors, Kainic Acid metabolism
Receptors, N-Methyl-D-Aspartate metabolism
Aspartic Acid analogs & derivatives
Astrocytes drug effects
Astrocytes metabolism
Central Nervous System Agents pharmacology
Glutamic Acid metabolism
Sodium metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1872-6240
- Volume :
- 1316
- Database :
- MEDLINE
- Journal :
- Brain research
- Publication Type :
- Academic Journal
- Accession number :
- 20026319
- Full Text :
- https://doi.org/10.1016/j.brainres.2009.12.028